| Literature DB >> 35114888 |
Lanuza A P Faccioli1, Zehra N Kocas-Kilicarslan1, Ricardo Diaz-Aragon1, Takashi Motomura1, Sriram Amirneni1, Michelle R Malizio1, Michael C Coard1, Carla Frau1, Nils Haep1, Rodrigo M Florentino1,2, Alina Ostrowska1,2.
Abstract
The use of primary human hepatocytes has been hampered by limited availability of adequate numbers of fresh and viable cells due to the ongoing shortage of liver donors. Thus, there is no surplus of healthy organs from which freshly isolated cells can be prepared when needed. However, primary hepatocytes can be successfully isolated from explanted liver specimens obtained from patients receiving orthotopic liver transplantation for decompensated liver cirrhosis or for metabolic liver disease without end-stage liver disease and are a valuable resource for the pharmaceutical industry research. This review focuses on the isolation, characterization and cryopreservation of hepatocytes derived from therapeutically resected livers with various hepatic diseases.Entities:
Keywords: Hepatocyte isolation; cryopreservation; diseased liver; drug screening
Mesh:
Year: 2021 PMID: 35114888 PMCID: PMC9208801 DOI: 10.1080/15476278.2021.1992216
Source DB: PubMed Journal: Organogenesis ISSN: 1547-6278 Impact factor: 2.316